Infection, inflammation, and infarction: Does acute endothelial dysfunction provide a link?

Lancet

Volumn 349, Issue 9062, 1997, Pages 1391-1392

  Vallance, Patrick ^a   Collier, Joe ^b   Bhagat, Kiran ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; HEART INFARCTION; HUMAN; INFECTION; INFLAMMATION; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; VASCULAR ENDOTHELIUM;

EID: 0030948839     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)09424-X     Document Type: Note

References (30)

1. Woodhouse PR, Khaw KT, Plummer M, Foley A, Meade TW. Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet. 1994; 343: 435-39.
2. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986; 314: 488-500.
3. Tillett HE, Smith JW, Gooch CD. Excess deaths attributed to influenza in England and Wales: age at death and certified cause. Int J Epidemiol 1983; 12: 344-52.
4. Valtonen V, Kuikka A, Syrjanen J. Thrombo-embolic complications in bacteraemic infections. Eur Heart J 1993; 14 (suppl K): 20-23.
5. Baigrie RJ, Lamont PM, Whiting S, Morris PJ. Portal endotoxin and cytokine responses during abdominal aortic surgery. Am J Surg 1993; 166: 248-51.
6. Mamode N, Cobbe S, Pollock JG. Infarcts after surgery. BMJ 1995; 310: 1215-16.
7. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331: 417-24.
8. Brody JI, PickeringNJ, Capuzzi DM, Fink GB, Can CA, Gomez F. Interleukin-1 alpha as a factor in occlusive vascular disease. Am J Clin Pathol 1992; 97: 8-13.
9. Kanda T, Hirac Y, Oshima S, et al. Interleukin-8 as a sensitive marker of unstable coronary artery disease. Am J Cardiol 1996; 77: 304-07.
10. Gates P, Marwood S, Jelinek M, Scott M. Unreported symptomatic and asymptomatic ischaemic heart disease in patients presenting with TIA or minor stroke detected by the London School of Hygiene Cardiovascular Questionnaire and Minnesota coding of a routine ECG. Clin Exp Neurol 1987; 24: 21-25.
11. Vallance P. Vascular endothelium, its physiology and pathophysiology. In: Wetherall DJ, Ledingham JGG, Warrell DA, eds. Oxford tesxtbook of medicine. Oxford: Oxford University Press, 1995: 2295-300.
12. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990; 323: 27-36.
13. Friedman HM. Infection of endothelial cells by common human viruses. Rev Infect Dis 1989; 11 (suppl 4): S700-04.
14. Visseren F, Bouter K, Bouwman J, Erkelens D, Diepersloot R. Procoagulant activity of endothelial cells after infection with respiratory viruses. Eur J Clin Invest 1996; 26: A8 (abstr).
15. Paleolog EM, Delasalle SA, Buurman WA, Feldmann M. Functional activities of receptors for tumor necrosis factor-alphon vascular endothelial cells. Blood. 1994; 84: 2578-90.
16. Bhagat K, Collier J, Vallance P. Endothelial stunning following a brief exposure to endotoxin: a mechanism to link infection to infarction? Cardiovasc Res 1996; 32: 822-29.
17. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-76.
18. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327: 524-26.
19. Moncada S, Higgs EA. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995; 9: 1319-30.
20. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm aterial bed of patients with insulin-dependent diabetes. J Clin Invest 1992; 90: 2548-54.
21. Chowienczyk PJ, Watts GF, Cockcroft JR, Ritter JM. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 1992; 340: 1430-32.
22. Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991; 83: 391-401.
23. Myers PR, Parker JL, TannerMA, Adams HR. Effects of cytokines tumor necrosis factor alpha and interleukin 1 beta on endotoxin-mediated inhibition of endothelium-derived relaxing factor bioactivity and nitric oxide production vascular in endothelium. Shock 1994; 1: 73-78.
24. Wang P, Ba ZE, Chaudry IH. Administration of tumor necrosis factor-alpha in vivo depresses endothelium-dependent relaxation. Am J Physiol 1994; 266: H2535-41.
25. Habib A, Creminon C, Frobert Y, Grassi J, Predelles P, Maclouf J. Demonstration of an inducible cyclooxygenase in human endothelial cells using antibodies raised against the carboxyl-terminal region of the cyclooxygenase-2. J Biol Chem 1993; 268: 23448-54.
26. Siegfried MR, Ma XL, Lefer AM. Splanchnic vascular endothelial dysfunction in rat endotoxemia: role of superoxide radicals. Eur J Pharmacol 1992; 212: 171-76.
27. Yoshizumi M, Perrella MA, Burnett Jr JC, Lee ME. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 1993; 73: 205-09.
28. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323: 236-41.
29. Hornig B, Maier V, Drexler H. Physical training improves endothelial function in patients with chronic heart failure. Circulation 1996; 93: 210-14.
30. Smith CJ, Sun D, Hoegler C, et al. Reduced gene expression of vascular endothelial NO synthase and cyclooxygenase-1 in heart failure. Circ Res 1996; 78: 58-64.